MEIP vs WHLM Comparison

MEI Pharma Inc is focused on the clinical development of novel therapies for cancer. The company's clinical drug candidate includes Pracinostat, an orally available histone deacetylase inhibitor for the treatment of patients with acute myeloid leukemia and myelodysplastic syndrome. Its clinical development portfolio also includes Zandelisib, an oral inhibitor of phosphatidylinositide 3-kinase delta for the treatment of patients with recurrent chronic lymphocytic leukemia or follicular non-Hodgkin's lymphoma; and ME-344, an isoflavone-based mitochondrial inhibitor for the treatment of HER2-negative breast cancer and Pracinostat, an oral histone deacetylase inhibitor. Geographically, all the business activities function through the region of the United States.

Wilhelmina International Inc is engaged in the business of fashion model management. The company provides traditional, full-service fashion model and talent management services, specializing in the representation and management of models, entertainers, artists, athletes and another talent to various clients which include retailers, designers, advertising agencies, print and electronic media and catalog companies. In addition, the company is also engaged in providing fashion modeling and talent product endorsement services to clients such as advertising agencies, branded consumer goods companies, fashion designers, magazine publications, retailers, department stores, product catalogs and Internet sites.